Novavax, Inc. (NVAX) has a market capitalization of $1.37B and trades at $8.39. The 52-week range is 5.01-11.97.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 3.1, Earnings Per Share (EPS) of $2.72, annual revenue of $1.12B.
The stock has a beta of 2.65, operates in the Healthcare sector.
